Skip to main content
SpringerLink
Log in

A method for the quantification of benzodiazepine receptors by using123I-iomazeniI and SPECT with one scan and one blood sampling

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Iodine-123-iomazenil (Iomazenil) is a ligand of central type benzodiazepine receptors for single photon emission computed tomography (SPECT). Previously we reported a simple, table look-up method for quantification of its binding potential (BP) by using two SPECT scans and calibrated standard input function with one blood sampling. This method is based on a two-compartment model (K1: influx rate constant; k2: efflux rate constant; Vd (= K1/k2): the total distribution volume corresponding BP), and requires two SPECT scans for calculating both K1 and Vd values. If the K1 value in the two-compartment model can be assumed to be constant, the radioactivity of one SPECT scan at 180 min after injection can be considered to tabulate as a function of Vd for a given K1 value and a given input function, and a table look-up procedure provides the corresponding Vd value. The purpose of this study was to develop a simple, autoradiographic method for quantification of BP by using one SPECT scan and calibrated standard input function with one blood sampling. SPECT studies were performed on 14 patients. A dynamic SPECT scan was initiated following an intravenous bolus injection of Iomazenil. A static SPECT scan was performed at 180 min after the injection. Frequent blood sampling from the brachial artery was performed on all subjects to determine the arterial input function. Simulation studies revealed that errors in calculated Vd values were around ± 10–15% for varied K1 values. A good correlation was observed between total distribution volume values calculated by three-compartment model analysis and those calculated by the present method (r = 0.90), supporting the validity of this method. The present method is simple and applicable for clinical use, and will be able to provide images of BP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Similar content being viewed by others

References

  1. Beer H-F, Blauenstein PA, Hasler PH, Delaloye B, Riccabona G, Bangerl I, et al.In vitro andin vivo evaluation of iodine-123-Ro 16-0154: A new imaging agent for SPECT investigations of benzodiazepine receptors.J Nucl Med 31: 1007–1014, 1990.

    PubMed  CAS  Google Scholar 

  2. Innis RB, Zoghbi SS, Johnson EW, Woods SW, Al-Tikriti MS, Baldwin RM, et al. SPECT imaging of the benzodiazepine receptor in non-human primate brain with [123I]Ro 16-0154.Eur J Pharmacol 193: 249–252, 1991.

    Article  PubMed  CAS  Google Scholar 

  3. Innis RB, Al-Tikriti MS, Zoghbi SS, Baldwin RM, Sybirska EH, Laruelle M, et al. SPECT imaging of the benzodiazepine receptor: Feasibility ofin vivo potency measurements from stepwise displacement curves.J Nucl Med 32: 1754–1761, 1991.

    PubMed  CAS  Google Scholar 

  4. Woods SW, Seibyl JP, Goddard AW, Dey HM, Zoghbi SS, Germine M, et al. Dynamic SPECT imaging after injection of the benzodiazepine receptor ligand [123I]iomazenil in healthy human subjects.Psych Res Neuroimaging 45: 67–77, 1992.

    Article  CAS  Google Scholar 

  5. Huffelen AC, Isselt JW, Veelen CWM, Rijk PP, Bentum AM, Dive D, et al. Identification of the side of the epileptic focus with123I-Iomazenil SPECT. A comparison with18FDG-PET and ictal EEG findings in patients with medically intractable complex partial seizures.Acta Neurochir Suppl 50: 95–99, 1990.

    Google Scholar 

  6. Bartenstein P, Ludolph A, Schober O, Lottes G, Scheidhauer K, Sciuk J, et al. Benzodiazepine receptors and cerebral blood flow in partial epilepsy.Eur J Nucl Med 18: 111–118, 1991.

    Article  PubMed  CAS  Google Scholar 

  7. Schubiger PA, Hasler PH, Beer-Wohlfahrt H, Bekier A, Oettli R, Cordes M, et al. Evaluation of a multicentre study with iomazenil — a benzodiazepine receptor ligand.Nucl Med Commun 12: 569–582, 1991.

    Article  PubMed  CAS  Google Scholar 

  8. Cordes M, Henkes H, Ferstl F, Schmitz B, Hierholzer J, Schmidt D, et al. Evaluation of focal epilepsy: A SPECT scanning comparison of 123-I-iomazenil versus HM-PAO.AJNR 13: 249–253, 1992.

    PubMed  CAS  Google Scholar 

  9. Johnson EW, Lanerolle NC, Kim JH, Sundaresan S, Spencer DD, Mattson RH, et al. “Central” and “peripheral” benzodiazepine receptors: Opposite changes in human epileptogenic tissue.Neurology 42: 811–815, 1992.

    PubMed  CAS  Google Scholar 

  10. Owen F, Poulter M, Waddington JL, Mashal RD, Crow TJ. [3H]R05-4864 and [3H]flunitrazepam binding in kainatelesioned rat striatum and in temporal cortex of brains from patients with senile dementia of the Alzheimer type.Brain Res 278: 373–375, 1983.

    Article  PubMed  CAS  Google Scholar 

  11. Reisine TD, Wastek GJ, Speth RC, Bird ED, Yamamura HI. Alterations in benzodiazepine receptor of Huntington’s diseased human brain.Brain Res 165: 183–187, 1979.

    Article  PubMed  CAS  Google Scholar 

  12. Onodera H, Sato G, Kogure K. GABA and benzodiazepine receptors in the gerbil brain after transient ischemia: Demonstration by quantitative receptor autoradiography.J Cereb Blood Flow Metab 7: 82–88, 1987.

    PubMed  CAS  Google Scholar 

  13. Sette G, Baron JC, Young AR, Miyazawa H, Tillet I, Barre L, et al.In vivo mapping of brain benzodiazepine receptor changes by PET after focal ischemia in the anesthetized baboon.Stroke 24: 2046–2058, 1993.

    PubMed  CAS  Google Scholar 

  14. Al-Tikriti MS, Dey HM, Zoghbi SS, Baldwin RM, Zea-Ponce Y, Innis RB. Dual-isotope autoradiographic measurement of regional blood flow and benzodiazepine receptor availability following unilateral middle cerebral artery occlusion.Eur J Nucl Med 21: 196–202, 1994.

    Article  PubMed  CAS  Google Scholar 

  15. Hatazawa J, Satoh T, Shimosegawa E, Okudera T, Inugami A, Ogawa T, et al. Evaluation of cerebral infarction with iodine 123-iomazenil SPECT.J Nucl Med 36: 2154–2161, 1995.

    PubMed  CAS  Google Scholar 

  16. Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ. A quantitative model for thein vivo assessment of drug binding sites with positron emission tomography.Ann Neurol 15: 217–227, 1984.

    Article  PubMed  CAS  Google Scholar 

  17. Wong DF, Gjedde A, Wagner HN Jr. Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands.J Cereb Blood Flow Metab 6: 137–146, 1986.

    PubMed  CAS  Google Scholar 

  18. Wong DF, Gjedde A, Wagner HN Jr, Dannais RF, Douglass KH, Links JM, et al. Quantification of neuroreceptors in the living human brain. II. Inhibition studies of receptor density and affinity.J Cereb Blood Flow Metab 6: 147–153, 1986.

    PubMed  CAS  Google Scholar 

  19. Farde L, Eriksson L, Blomquist G, Halldin C. Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET — A comparison to the equilibrium analysis.J Cereb Blood Flow Metab 9: 696–708, 1989.

    PubMed  CAS  Google Scholar 

  20. Blomqvist G, Pauli S, Farde L, Eriksson L. Maps of receptor binding parameters in the human brain — a kinetic analysis of PET measurements.Eur J Nucl Med 16: 257–265, 1990.

    Article  PubMed  CAS  Google Scholar 

  21. Koeppe RA, Holthoff VA, Frey KA, Kilbourn MR, Kuhl DE. Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography.J Cereb Blood Flow Metab 11: 735–744, 1991.

    PubMed  CAS  Google Scholar 

  22. Holthoff VA, Koeppe RA, Frey KA, Paradise AH, Kuhl DE. Differentiation of radioligand delivery and binding in the brain: Validation of a two-compartment model for [11C]flumazenil.J Cereb Blood Flow Metab 11: 745–752, 1991.

    PubMed  CAS  Google Scholar 

  23. Price JC, Mayberg HS, Dannals RF, Wilson AA, Ravert HT, Sadzot B, et al. Measurement of benzodiazepine receptor number and affinity in humans using tracer kinetic modeling, positron emission tomography, and [11C]flumazenil.J Cereb Blood Flow Metab 13: 656–667, 1993.

    PubMed  CAS  Google Scholar 

  24. Laruelle M, Baldwin RM, Rattner Z, Al-Tikriti MS, Zea-Ponce Y, Zoghbi SS, et al. SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in non-human primates: I. Kinetic modeling of single bolus experiments.J Cereb Blood Flow Metab 14: 439–452, 1994.

    PubMed  CAS  Google Scholar 

  25. Laruelle M, Abi-Dargham A, Al-Tikriti MS, Baldwin RM, Zea-Ponce Y, Zoghbi SS, et al. SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: II. Equilibrium analysis of constant infusion experiments and correlation within vitro parameters.J Cereb Blood Flow Metab 14: 453–465, 1994.

    PubMed  CAS  Google Scholar 

  26. Abi-Dargham A, Laruelle M, Seibyl J, Rattner Z, Baldwin RM, Zoghbi SS, et al. SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: Kinetic and equilibrium paradigms.J Nucl Med 35: 228–238, 1994.

    PubMed  CAS  Google Scholar 

  27. Abi-Dargham A, Gandelman M, Zoghbi SS, Laruelle M, Baldwin RM, Randall P, et al. Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil.J Nucl Med 36: 167–175, 1995.

    PubMed  CAS  Google Scholar 

  28. Onishi Y, Yonekura Y, Mukai T, Nishizawa S, Tanaka F, Okazawa H, et al. Simple quantification of benzodiazepine receptor binding and ligand transport using iodine-123-iomazenil and two SPECT scans.J Nucl Med 36: 1201–1210, 1995.

    PubMed  CAS  Google Scholar 

  29. Huang SC, Barrio JR, Phelps ME. Neuroreceptor assay with positron emission tomography. Equilibrium versus dynamic approaches.J Cereb Blood Flow Metab 6: 515–521, 1986.

    PubMed  CAS  Google Scholar 

  30. Lassen NA. Neuroreceptor quantitationin vivo by the steady-state principle using constant infusion or bolus injection of radioactive tracers.J Cereb Blood Flow Metab 12: 709–716, 1992.

    PubMed  CAS  Google Scholar 

  31. Ito H, Goto R, Koyama M, Kawashima R, Ono S, Sato K, et al. A simple method for the quantification of benzodiazepine receptors using iodine-123 iomazenil and singlephoton emission tomography.Eur J Nucl Med 23: 782–791, 1996.

    Article  PubMed  CAS  Google Scholar 

  32. Iida H, Itoh H, Bloomfield PM, Munaka M, Murakami M, Inugami A, et al. A method to quantitate cerebral blood flow using a rotating gamma camera and iodine-123 iodoamphetamine with one blood sampling.Eur J Nucl Med 21: 1072–1084, 1994.

    Article  PubMed  CAS  Google Scholar 

  33. Itoh H, Iida H, Murakami M, Bloomfield PM, Miura S, Okudera T, et al. A method for measurement of regional cerebral blood flow using N-isopropyl-p-[123I]iodoamphetamine (123I-IMP) SPECT; two scans with one point blood sampling technique.KAKU IGAKU (Jpn J Nucl Med) 29: 1193–1200, 1992.

    CAS  Google Scholar 

  34. Ito H, Koyama M, Goto R, Kawashima R, Ono S, Atsumi H, et al. Cerebral blood flow measurement with iodine-123-IMP SPECT, calibrated standard input function and venous blood sampling.J Nucl Med 36: 2339–2342, 1995.

    PubMed  CAS  Google Scholar 

  35. Ito H, Ishii K, Atsumi H, Kinoshita T, Kawashima R, Ono S, et al. Error analysis of table look-up method for cerebral blood flow measurement by123I-IMP brain SPECT: Comparison with conventional microsphere model method.Ann Nucl Med 9: 75–80, 1995.

    Article  PubMed  CAS  Google Scholar 

  36. Zoghbi SS, Baldwin RM, Seibyl JP, Al-Tikriti MS, Zea-Ponce Y, Lamelle M, et al. Pharmacokinetics of the SPECT benzodiazepine receptor radioligand [123I]iomazenil in human and non-human primates.Nucl Med Biol 19: 881–888, 1992.

    CAS  Google Scholar 

  37. Kimura K, Hashikawa K, Etani H, Uehara A, Kozuka T, Moriwaki H, et al. A new apparatus for brain imaging: fourhead rotating gamma camera single-photon emission computed tomography.J Nucl Med 31: 603–609, 1990.

    PubMed  CAS  Google Scholar 

  38. Chang LT. A method for attenuation correction in radionuclide computed tomography.IEEE Trans Nucl Sci 25: 638–643, 1978.

    Article  Google Scholar 

  39. Chang LT. Attenuation correction and incomplete projection in single photon emission computed tomography.IEEE Trans Nucl Sci 26: 2780–2789, 1979.

    Article  Google Scholar 

  40. Renkin EM. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles.Am J Pkysiol 197: 1205–1210, 1959.

    CAS  Google Scholar 

  41. Crone C. Permeability of capillaries in various organs as determined by use of the indicator diffusion method.Acta Physiol Scand 58: 292–305, 1963.

    Article  PubMed  CAS  Google Scholar 

  42. Neider JA, Mead R. A simplex method for function minimization.Computer J 7: 308–312, 1965.

    Google Scholar 

  43. Koeppe RA, Mangner T, Betz AL, Shulkin BL, Allen R, Kollros P, et al. Use of [11C]aminocyclohexanecarboxylate for the measurement of amino acid uptake and distribution volume in human brain.J Cereb Blood Flow Metab 10: 727–739, 1990.

    PubMed  CAS  Google Scholar 

  44. Onishi Y, Yonekura Y, Nishizawa S, Tanaka F, Okazawa H, Ishizu K, et al. Noninvasive quantification of iodine-123-iomazenil SPECT.J Nucl Med 37: 374–378, 1996.

    PubMed  CAS  Google Scholar 

  45. Ito H, Ishii K, Atsumi H, Inukai Y, Abe S, Sato M, et al. Error analysis of autoradiography method for measurement of cerebral blood flow by123I-IMP brain SPECT: A comparison study with table look-up method and microsphere model method.Ann Nucl Med 9: 185–190, 1995.

    PubMed  CAS  Google Scholar 

  46. Iida H, Itoh H, Nakazawa M, Hatazawa J, Nishimura H, Onishi Y, et al. Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT.J Nucl Med 35: 2019–2030, 1994.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine and Radiology, Division of Brain Sciences, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, 980-77, Sendai, Japan

    Hiroshi Ito, Ryuta Kawashima, Masamichi Koyama, Ryoui Goto, Kazunori Sato, Shuichi Ono & Hiroshi Fukuda

Authors
  1. Hiroshi Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ryuta Kawashima
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masamichi Koyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ryoui Goto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kazunori Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shuichi Ono
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hiroshi Fukuda
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ito, H., Kawashima, R., Koyama, M. et al. A method for the quantification of benzodiazepine receptors by using123I-iomazeniI and SPECT with one scan and one blood sampling. Ann Nucl Med 11, 101–108 (1997). https://doi.org/10.1007/BF03164817

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03164817

Key words

Search

Navigation